Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 8, 2008, Pages 2937-2939

  Mokrousov, Igor ^a,b   Otten, Tatiana ^c   Manicheva, Olga ^c   Potapova, Yulia ^c   Vishnevsky, Boris ^c   Narvskaya, Olga ^a   Rastogi, Nalin ^b  

^a ST PETERSBURG PASTEUR INSTITUTE   (Russian Federation)

^b Institut Pasteur de Guadeloupe   (Guadeloupe)

^c ST PETERSBURG RESEARCH INSTITUTE OF PHTHISIOPULMONOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; KANAMYCIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; GENE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; GYRA GENE; GYRB GENE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DNA GYRASE; GENOTYPE; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; RUSSIA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 48749111879     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00036-08     Document Type: Article

References (22)

1. Aubry, A., N. Veziris, E. Cambau, C. Truffot-Pernot, V. Jarlier, and L. M. Fisher. 2006. Novel gyrase mutations in quinolone-resistant and -hypersus-ceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes. Antimicrob. Agents Chemother. 50:104-112.
2. Chan, R. C., M. Hui, E. W. Chan, T. K. Au, M. L. Chin, C. K. Yip, C. K. AuYeang, C. Y. Yeung, K. M. Kam, P. C. Yip, and A. F. Cheng. 2007. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J. Antimicrob. Chemother. 59:866-873.
3. Drobniewski, F., Y. Balabanova, V. Nikolayevsky, M. Ruddy, S. Kuznetzov, S. Zakharova, A. Melentyev, and I. Fedorin. 2005. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 293:2726-2731.
4. Escribano, I., J. C. Rodriguez, B. Llorca, E. Garcia Pachon, M. Ruiz, and G. Royo. 2007. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy 53:397-401.
5. Giannoni, F., E. Iona, F. Sementilli, L. Brunori, M. Pardini, G. B. Migliori, G. Orefici, and L. Fattorini. 2005. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:2928-2933.
6. Gilman, J., and M. Myatt. 1998. EpiCalc 2000, version 1.02. Brixton Books, London, United Kingdom.
7. Huang, T. S., C. M. Kunin, S. Shin-Jung Lee, Y. S. Chen, H. Z. Tu, and Y. C. Liu. 2005. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J. Antimicrob. Chemother. 56:1058-1062.
8. Iwamoto, T., S. Yoshida, K. Suzuki, M. Tomita, R. Fujiyama, N. Tanaka, Y. Kawakami, and M. Ito. 2007. Hypervariable loci that enhance the discriminatory ability of newly proposed 15-loci and 24-loci variable-number tandem repeat typing method on Mycobacterium tuberculosis strains predominated by the Beijing family. FEMS Microbiol. Lett. 270:67-74. (Erratum, 272:282-283.)
9. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. D. A. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
10. Mdluli, K., and Z. Ma. 2007. Mycobacterium tuberculosis DNA gyrase as a target for drug discovery. Infect. Disord. Drug Targets 7:159-168.
11. Mokrousov, I. 2004. Multiple rpoB mutants of Mycobacterium tuberculosis and second-order selection of hypermutable alleles. Emerg. Infect. Dis. 10:1337-1338.
12. Mokrousov, I., O. Narvskaya, T. Otten, E. Limeschenko, L. Steklova, and B. Vyshnevskyi. 2002. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob. Agents Chemother. 46:1417-1424.
13. Mokrousov, I., T. Otten, A. Vyazovaya, E. Limeschenko, M. L. Filipenko, C. Sola, N. Rastogi, L. Steklova, B. Vyshnevskiy, and O. Narvskaya. 2003. PCR-based methodology for detecting multidrug-resistant strains of Myco bacterium tuberculosis Beijing family circulating in Russia. Eur. J. Clin. Microbiol. Infect. Dis. 22:342-348.
14. Mokrousov, I., T. Otten, B. Vyshnevskiy, and O. Narvskaya. 2002. Detection of embB306 mutations in ethambutol-susceptible Mycobacterium tuberculosis clinical isolates from northwestern Russia: implications for genotypic resistance testing. J. Clin. Microbiol. 40:3810-3813.
15. Mokrousov, I., W. W. Jiao, G. Z. Sun, J. W. Liu, M. Li, O. Narvskaya, and A. D. Shen. 2006. Evaluation of the rpoB macroarray assay to detect rifampin resistance and comparison with population structure of Mycobacterium tuberculosis in Beijing, China. Eur. J. Clin. Microbiol. Infect. Dis. 25:703-710.
16. Narvskaya, O., I. Mokrousov, T. Otten, and B. Vishnevsky. 2005. Molecular markers: application for studies of Mycobacterium tuberculosis population in Russia, p. 111-125. In M. M. Read (ed.), Trends in DNA fingerprinting research. Nova Science Publishers, New York, NY.
17. Shi, R., J. Zhang, C. Li, Y. Kazumi, and I. Sugawara. 2006. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing. J. Clin. Microbiol. 44:4566-4568.
18. Siddiqi, N., M. Shamim, S. Hussain, R. K. Choudhary, N. Ahmed, Prachee, S. Banerjee, G. R. Savithri, M. Alam, N. Pathak, A. Amin, M. Hanief, V. M. Katoch, S. K. Sharma, and S. E. Hasnain. 2002. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob. Agents Chemother. 46:443-450.
19. Supply, P., C. Allix, S. Lesjean, M. Cardoso-Oelemann, S. Rusch-Gerdes, E. Willery, E. Savine, P. de Haas, H. van Deutekom, S. Roring, P. Bifani, N. Kurepina, B. Kreiswirth, C. Sola, N. Rastogi, V. Vatin, M. C. Gutierrez, M. Fauville, S. Niemann, R. Skuce, K. Kremer, C. Locht, and D. van Soolingen. 2006. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 44:4498-4510.
20. Takiff, H. E., L. Salazar, C. Guerrero, W. Philipp, W. M. Huang, B. Kreiswirth, S. T. Cole, W. R. Jacobs, Jr., and A. Telenti. 1994. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38:773-780.
21. Wang, J. Y., L. N. Lee, H. C. Lai, S. K. Wang, I. S. Jan, C. J. Yu, P. R. Hsueh, and P. C. Yang. 2007. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. J. Antimicrob. Chemother. 59:860-865.
22. World Health Organization. 2006. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly. Epidemiol. Rec. 81:430-432.